OECD · Health

Norway: Pharmaceutical sales: Antiinfectives for systemic use, US dollars per person, PPP converted

77US dollars per person, PPP converted · 2025+79.5% since 2015

OECD dataflow OECD.ELS.HD:HEALTH_PHMC@DF_PHMC_SALES. Pharmaceutical sales: Antiinfectives for systemic use (US dollars per person, PPP converted). Annual figures for Norway from 2000 to 2025.

20002025

Every year

YearValue (US dollars per person, PPP converted)Note
202577
202470.5
202363.5
202276.9
202162.9
202033.2
201942.1
201843.2
201745.7
201643.3
201542.9
201438.4
201333
201233.8
201131.7
201028.1
200935.2
200830.3
200729
200627.9
200523.9
200422.2
200321.2
200220.2
200115.8
200015.6

Source

Published by OECD, produced by OECD. Licence: OECD terms (CC BY 4.0). Retrieved 2026-11-17.

The dataset for every country, with quality and provenance →

Cite or download

OECD (2026). Pharmaceutical sales: Antiinfectives for systemic use, US dollars per person, PPP converted. Interva. https://interva.co/dataset/oecd-df-phmc-sales-ph-sales-z-j-usd-ppp-ps (accessed 2026-11-21). catalog snapshot 2026-11-17.

JSON, NorwayAPI and MCP

Pharmaceutical sales: Antiinfectives for systemic use, US dollars per person, PPP converted in other countries

Rank Norway against its region, see where publishers disagree, or ask a question in plain words on the Interva desk.

Norway: Pharmaceutical sales: Antiinfectives for systemic use, US dollars per person, PPP converted (2000–2025) · Interva